Slovakia - Re-Imbursed Pharmaceutical Market
Since 2014, Slovakia Re-Imbursed Pharmaceutical Market decreased by 7.8points year on year. At 25.2 Percent of Generics in Value in 2019, the country was number 8 comparing other countries in Re-Imbursed Pharmaceutical Market. Slovakia is overtaken by Greece, which was number 7 at 25.3 Percent of Generics in Value and is followed by Portugal with 25 Percent of Generics in Value. Austria lead the ranking with 52.2 Percent of Generics in Value in 2019, that is +2.8points versus 2018. United Kingdom, Turkey and New Zealand respectively ranked number 2, 3 and 4 in this ranking. Denmark recorded the best 5 years average growth at +6.9points per year, while Slovakia recorded the worst performance at -7.8points per year.
Loading...
| Date | Percent of Generics in Value |
|---|---|
| 2019 | 25.20 |
| 2018 | 26.30 |
| 2017 | 27.10 |
| 2016 | 27.20 |
| 2015 | 36.50 |
How does Slovakia rank in Re-Imbursed Pharmaceutical Market?
| # | 17 Countries | Percent of Generics in Value | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Austria
|
52.20 % | 2019 | +2.8 % | +2.2 % | View data | |
| 2 |
#2
United Kingdom
|
38.50 % | 2019 | +2.1 % | +2.6 % | View data | |
| 7 |
#7
Greece
|
25.30 % | 2019 | +11.9 % | +5.9 % | View data | |
| 8 |
#8
Slovakia
|
25.20 % | 2019 | -4.2 % | -7.8 % | View data | |
| 9 |
#9
Portugal
|
25.00 % | 2019 | -1.6 % | +0.7 % | View data | |